Product Name: Gliclazide CAS NO:21187-98-4
Chemical & Physical Properties:
Appearance: white powder
Gliclazide is a second-generation sulfonylurea oral hypoglycemic agent. It has the dual effects of lowering blood sugar and improving blood coagulation. It can not only improve the metabolism of diabetic patients, but also improve or delay the occurrence of diabetic vascular complications. Developed by the French company SERVIER, it was first launched in France in 1972. It is mainly used for mild and moderate type II diabetes with no ketosis tendency and no ketosis tendency, and it can also improve the ocular fundus pathology of diabetic patients. Disorders of metabolism and vascular function. It can be combined with biguanide oral hypoglycemic agents, combined with insulin to treat insulin-dependent diabetes, which can reduce the amount of insulin.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.